Skip to main content
About CLAs



MRI and/or CT imaging of affected areas is recommended as the first screening imaging for suspected CLAs.

Skeletal survey or radiographs recommended as second imaging technique and for long-term monitoring.

Dynamic contrast-enhanced magnetic resonance lymphangiogram (DCMRL) may be needed to image the central lymphatics.

Providers may recommend one or more of the following tests to aid in a diagnosis and monitoring:

  • Biopsy
  • Bone scan
  • Bronchoscopy
  • CT scan
  • MRI
  • Lymphangiogram
  • Skeletal survey
  • Ultrasound
  • X-ray

Laboratory evaluation often includes

  • Complete blood count (CBC), complete metabolic panel (CMP), and coagulation studies
  • Immune testing may be required

Genetic testing

  • Genetic testing of involved tissue is needed to help identify potential causative somatic gene variants and guide targeted therapy
  • Important to keep in mind that
    • Affected tissue must be tested due to the nature of somatic variants (not present in all cells)
    • While affected tissue must be the sample used for genetic testing, the frequency of mutations in affected tissue is low which can make it difficult to detect mutations

Thank you to our partners.